Home
>
Product
>
Antibody
>
Rabbit Anti-Phospho-MYL(Ser19)/FITC Conjugated antibody
background:
Thus gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]
Subunit:
Myosin is a hexamer of 2 heavy chains and 4 light chains.
Subcellular Location:
Cytoplasm, myofibril, sarcomere, A band
Post-translational modifications:
N-terminus is methylated by METTL11A/NTM1.
Phosphorylated by MYLK3.
DISEASE:
Defects in MYL2 are the cause of familial hypertrophic cardiomyopathy type 10 (CMH10) [MIM:608758]. Familial hypertrophic cardiomyopathy is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
Similarity:
Contains 3 EF-hand domains.
Database links:
Entrez Gene: 4633 Human
Entrez Gene: 17906 Mouse
Entrez Gene: 363925 Rat
Omim: 160781 Human
SwissProt: P10916 Human
SwissProt: P51667 Mouse
SwissProt: P08733 Rat
Unigene: 75535 Human
Unigene: 1529 Mouse
Unigene: 37176 Rat
Unigene: 6534 Rat
Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
|
|